Australian Clinical Labs Limited (ASX:ACL)
Australia
· Delayed Price · Currency is AUD 2.820
+0.030 (1.08%)
At close: Dec 5, 2025
Australian Clinical Labs Revenue
In the fiscal year ending June 30, 2025, Australian Clinical Labs had annual revenue of 741.27M AUD with 6.45% growth. Australian Clinical Labs had revenue of 372.10M in the half year ending June 30, 2025, with 10.49% growth.
Revenue
741.27M
Revenue Growth
+6.45%
P/S Ratio
0.74
Revenue / Employee
157.72K
Employees
4,700
Market Cap
544.92M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 741.27M | 44.90M | 6.45% |
| Jun 30, 2024 | 696.37M | -704.00K | -0.10% |
| Jun 30, 2023 | 697.07M | -298.53M | -29.99% |
| Jun 30, 2022 | 995.60M | 348.90M | 53.95% |
| Jun 30, 2021 | 646.70M | 156.13M | 31.83% |
| Jun 30, 2020 | Pro | Pro | Pro |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| CSL Limited | 23.73B |
| Pro Medicus | 212.98M |
| Cochlear | 2.34B |
| Sonic Healthcare | 9.65B |
| Ramsay Health Care | 17.79B |
| Ansell | 3.06B |
| Telix Pharmaceuticals | 1.01B |
| Mesoblast | 26.23M |